| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/14787210.4.6.1039 |
| P698 | PubMed publication ID | 17181419 |
| P2093 | author name string | Paul G Auwaerter | |
| P2860 | cites work | Infectious agents and cancer: criteria for a causal relation | Q22251455 |
| Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus | Q25257251 | ||
| EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15 | Q28302555 | ||
| Acyclovir inhibition of Epstein-Barr virus replication | Q28366051 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Acute complications of Epstein-Barr virus infectious mononucleosis. | Q33332642 | ||
| Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation | Q33776109 | ||
| Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment | Q33859097 | ||
| Acyclovir for treatment of infectious mononucleosis: a meta-analysis | Q33890661 | ||
| Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro | Q33935329 | ||
| VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 | ||
| Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus | Q33993288 | ||
| A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis | Q33997176 | ||
| Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. | Q34105464 | ||
| Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis | Q34147153 | ||
| Epstein-Barr virus infections: prospects for treatment | Q34432651 | ||
| Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis | Q34557923 | ||
| Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis | Q34565138 | ||
| Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? | Q34568578 | ||
| Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study | Q34680728 | ||
| Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis | Q35017874 | ||
| Epstein-Barr virus-recent advances | Q35076846 | ||
| Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases | Q35110895 | ||
| Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects | Q35235144 | ||
| Infectious mononucleosis: return to play | Q35840584 | ||
| Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years | Q35857323 | ||
| Latent and lytic Epstein-Barr virus replication strategies | Q35896249 | ||
| IL-7 and IL-15: therapeutic cytokines for immunodeficiency | Q35998307 | ||
| Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. | Q36247163 | ||
| Infectious mononucleosis and corticosteroids: management practices and outcomes | Q36288787 | ||
| Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice | Q36327458 | ||
| Challenges for molecular profiling of chronic fatigue syndrome | Q36412667 | ||
| Cytomegalovirus and Epstein-Barr virus subtypes--the search for clinical significance | Q36477344 | ||
| Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. | Q36486650 | ||
| Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication | Q37734377 | ||
| Prevalence of Epstein-Barr virus in Japan: trends and future prediction | Q38438737 | ||
| Exposure to infant siblings during early life and risk of multiple sclerosis | Q39129736 | ||
| New perspectives in nutrition management of diabetes mellitus | Q39292353 | ||
| Dexamethasone for the treatment of sore throat in children with suspected infectious mononucleosis: a randomized, double-blind, placebo-controlled, clinical trial | Q39383820 | ||
| Birth order, atopy, and risk of non-Hodgkin lymphoma | Q40510360 | ||
| Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay | Q40558497 | ||
| Treatment of severe infectious mononucleosis with famciclovir | Q40580187 | ||
| Large clonal expansions of CD8+ T cells in acute infectious mononucleosis | Q40665903 | ||
| Neurologic complications of infectious mononucleosis | Q40688757 | ||
| Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells | Q40815204 | ||
| New antiherpesvirus agents. Their targets and therapeutic potential | Q41107151 | ||
| Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women | Q42647413 | ||
| Social class and infectious mononucleosis | Q42791231 | ||
| Early events in Epstein-Barr virus infection provide a model for B cell activation | Q42937446 | ||
| Encephalitis caused by Epstein-Barr virus in a renal transplant recipient | Q43820689 | ||
| Humoral immune response in infectious mononucleosis. Late emergence of anti-EA(R) and the effects of corticosteroid therapy | Q43913693 | ||
| Biology of Epstein-Barr virus during infectious mononucleosis | Q43971482 | ||
| Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions | Q44087148 | ||
| Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness | Q44271559 | ||
| Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. | Q44421315 | ||
| Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children | Q44546120 | ||
| An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus | Q44657983 | ||
| Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity | Q45263287 | ||
| Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study | Q45304939 | ||
| Ganciclovir and the treatment of Epstein-Barr virus hepatitis | Q45412054 | ||
| Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection | Q45423512 | ||
| A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis | Q45423513 | ||
| Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma | Q45722302 | ||
| Sexual history and Epstein-Barr virus infection | Q45731201 | ||
| Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load | Q45734533 | ||
| Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection | Q45748585 | ||
| Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy | Q45760204 | ||
| Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge | Q45846316 | ||
| Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis | Q46866923 | ||
| Analysis of immune activation and clinical events in acute infectious mononucleosis | Q47348964 | ||
| The relationship between fatigue, psychological and immunological variables in acute infectious illness. | Q51097736 | ||
| Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. | Q51829403 | ||
| Course and outcome of chronic fatigue in children and adolescents. | Q52038322 | ||
| Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. | Q53781119 | ||
| What advice do patients with infectious mononucleosis report being given by their general practitioner? | Q57356619 | ||
| Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis | Q57422892 | ||
| P433 | issue | 6 | |
| P921 | main subject | infectious mononucleosis | Q207367 |
| P304 | page(s) | 1039-1049 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? | |
| P478 | volume | 4 |
| Q34100847 | Environmental risk factors in multiple sclerosis |
| Q36784912 | Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy |
| Q37052179 | Hypothesis--ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers |
| Q24245428 | Steroids for symptom control in infectious mononucleosis |
| Q87192637 | Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA-mismatched sibling donor for active systemic epstein-barr virus-positive T-cell lymphoproliferative disease of childhood following primary |
Search more.